PPF
ALNY icon

PFA Pension Forsikringsaktieselskab’s Alnylam Pharmaceuticals ALNY Stock Holding History

PFA Pension Forsikringsaktieselskab’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$131K Sell
434
-59,266
-99% -$17.9M ﹤0.01% 413
2026
Q1 		$19.8M Buy
59,700
+24,295
+69% +$8.27M 0.06% 267
2025
Q4 		$14.1M Buy
+35,405
New +$15.7M 0.04% 288

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

PFA Pension Forsikringsaktieselskab's ALNY Position: Q2 2026 in Review

PFA Pension Forsikringsaktieselskab reduced its Alnylam Pharmaceuticals (ALNY) stake by 99% in Q2 2026, selling an estimated $17.9M and leaving 434 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #413.

PFA Pension Forsikringsaktieselskab first reported a position in ALNY in Q4 2025 and has held it in 3 quarters since. The position peaked at $19.8M in Q1 2026. 530 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • PFA Pension Forsikringsaktieselskab held 434 shares of Alnylam Pharmaceuticals worth $131K as of Q2 2026.
  • PFA Pension Forsikringsaktieselskab sold 59,266 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $17.9M.
  • Alnylam Pharmaceuticals made up ﹤0.01% of PFA Pension Forsikringsaktieselskab's portfolio in Q2 2026, its #413 holding.
  • PFA Pension Forsikringsaktieselskab first reported a position in Alnylam Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • PFA Pension Forsikringsaktieselskab's Alnylam Pharmaceuticals position peaked at $19.8M in Q1 2026.
  • 530 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on PFA Pension Forsikringsaktieselskab's 13F filing for Q2 2026, filed 12 Aug 2026.